Skip to main content

Low Vision

1
Pipeline Programs
2
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
4 programs
1
Socially Assistive Robot for Low Vision RehabilitationPhase 11 trial
Low Vision RehabilitationN/A1 trial
Low Vision RehabilitationN/A1 trial
Low Vision RehabilitationN/A1 trial
Active Trials
NCT04926974Completed145Est. Sep 2023
NCT04066075Completed61Est. Nov 2023
NCT06107881Recruiting350Est. Jun 2028
+1 more trials
Lighthouse Pharmaceuticals
Lighthouse PharmaceuticalsCA - San Francisco
1 program
Visual FeedbackN/A1 trial
Active Trials
NCT04929756Unknown106Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Angeles TherapeuticsSocially Assistive Robot for Low Vision Rehabilitation
Angeles TherapeuticsLow Vision Rehabilitation
Angeles TherapeuticsLow Vision Rehabilitation
Lighthouse PharmaceuticalsVisual Feedback
Angeles TherapeuticsLow Vision Rehabilitation

Clinical Trials (5)

Total enrollment: 682 patients across 5 trials

NCT04190134Angeles TherapeuticsSocially Assistive Robot for Low Vision Rehabilitation

Socially Assistive Robots to Enhance Magnification Device Use for Reading

Start: Apr 2022Est. completion: Feb 202520 patients
Phase 1Recruiting
NCT06107881Angeles TherapeuticsLow Vision Rehabilitation

Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision

Start: Dec 2023Est. completion: Jun 2028350 patients
N/ARecruiting
NCT04926974Angeles TherapeuticsLow Vision Rehabilitation

Community Access Through Remote Eyesight (CARE) Study

Start: Jun 2021Est. completion: Sep 2023145 patients
N/ACompleted
NCT04929756Lighthouse PharmaceuticalsVisual Feedback

Eye Movement Rehabilitation in Low Vision Patients

Start: Sep 2020Est. completion: Jan 2024106 patients
N/AUnknown
NCT04066075Angeles TherapeuticsLow Vision Rehabilitation

Beacon Sensors and Telerehabilitation for Low Vision

Start: Oct 2019Est. completion: Nov 202361 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 682 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.